GALAPAGOS NV-SPON ADR (GLPG) Stock News

Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus

Galapagos NV plans to split into two entities by mid-2025, focusing on oncology cell therapy and innovative medicines, with €2.45 billion allocated to SpinCo's pipeline.

Mentions: GILD

Why Trip.com Group Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

Mentions: GOTU SOPA SMFL BLDP ...

Galapagos Surges On An FDA Win For Its Rival To Gilead, Novartis; But There Are Some Caveats

The company is gearing up to rival giants Gilead and Novartis with a potentially decentralized CAR-T process.

Mentions: GILD NVS

GLPG Stock Earnings: Galapagos Beats EPS, Beats Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Galapagos (NASDAQ:GLPG) just reported results for the second quarter of 2024.Ga...

GLPG Stock Earnings: Galapagos Beats EPS, Misses Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Galapagos (NASDAQ:GLPG) just reported results for the first quarter of 2024.Gal...

GLPG Stock Earnings: Galapagos Beats EPS, Beats Revenue for Q2 2024

GLPG stock results show that Galapagos beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

BridGene Biosciences Expands Strategic Collaboration with Galapagos to Develop Selective Oral SMARCA2 PROTAC in Precision Oncology

/PRNewswire/ -- BridGene Biosciences, Inc., a leader in the discovery of small molecule drugs for traditionally "hard-to-drug" targets, today announced an...

GLPG Stock Earnings: Galapagos Beats EPS, Misses Revenue for Q1 2024

GLPG stock results show that Galapagos beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

GLPG Stock Earnings: Galapagos Beats EPS, Beats Revenue for Q3 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Galapagos (NASDAQ:GLPG) just reported results for the third quarter of 2023.Gal...

Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline

Galapagos enters into strategic collaboration with Thermo Fisher (NASDAQ:GLPG)

Galapagos NV enters strategic collaboration with Thermo Fisher for decentralized manufacturing of CAR-T product in San Francisco area, effective January...

Galapagos signs development deal with BridGene (NASDAQ:GLPG)

Galapagos (GLPG) has entered into a strategic collaboration deal with BridGene Biosciences, with Galapagos receiving the exclusive right to commercialize any resulting products.

BridGene Biosciences Announces Strategic Collaboration with Galapagos to Discover Small Molecule Drugs for Oncology Targets

/PRNewswire/ -- BridGene Biosciences, Inc., a leader in the discovery of small molecule drugs for traditional "hard-to-drug" targets, announced today a...

Galapagos to transfer Jyseleca business to Alfasigma (NASDAQ:GLPG)

Galapagos (GLPG) Tuesday said it entered into a deal to sell its Jyseleca business to Italian pharma company Alfasigma. Per the terms, Galapagos will receive a €50 million payment upfront..

GLPG Stock Earnings: Galapagos Beats EPS, Beats Revenue for Q3 2023

GLPG stock results show that Galapagos beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2023.